Video Library

This presentation discusses psychosocial challenges that can arise before, during and after a bone marrow/stem cell transplant or CAR T-cell therapy, strategies to manage them, resources that can help, and when to consult a mental health professional.

Bone marrow/stem cell transplant survivors can experience a number of skin problems after transplant. Monitoring yourself for skin abnormalities and seeking prompt treatment from a dermatologist can help relieve symptoms and prevent serious problems.

Graft-versus-host disease (GVHD) often affects the skin, nails, hair, mouth and/or genitals. This presentation will discuss potential treatments for various forms of acute and chronic skin GVHD, dry skin care, sun protection and how to monitor your skin for skin wounds and skin cancer.

Ocular graft-versus-host disease (GVHD) can cause tear loss, dry eyes, irritation, pain and vision problems and can impact quality of life after transplant. This presentation will discuss symptoms of ocular GVHD and effective treatments.

Chronic graft-versus-host disease (GVHD) of the mouth is a common side-effect of stem cell transplantation. This presentation describes the major types or oral GVHD and discusses the most effective remedies to treat this problem.

Graft-versus-host disease (GVHD) frequently affects the gastrointestinal tract and liver after a stem cell transplant using donor cells (allogenic transplant). There are two types of GVHD: acute and chronic. This presentation discusses the incidence, symptoms, risk factors for each and treatment options.

Graft-versus-host disease (GVHD) is a common complication after a bone marrow/stem cell transplant using donor cells (allogeneic transplant). This presentation will discuss current techniques to prevent GVHD, new drugs to treat acute and chronic GVHD and clinical trials testing new GVHD therapies.

Graft-versus-host disease (GVHD) is a common complication after a stem cell transplant. Extracorporeal photopheresis (ECP) can be an effective treatment for certain types of GVHD. This presentation explains how ECP works and its potential benefits for patients with significant GVHD.

The overall health of the gut microbiome and its organisms can influence the prevalence and severity of graft-versus-host disease. This presentation reviews the causes and mechanisms of how organisms in the gut can affect GVHD and reviews potential strategies to minimize this problem.

Chronic graft-versus-host disease (GVHD) is a common complication after a transplant using donor stem cells (allogeneic transplant) that target many organs, including the lungs. Learn who’s at risk of developing chronic GVHD in the lungs, how it affects breathing and therapies available to treat it.

Maintenance therapy after a stem cell transplant is used to decrease early death, increase time to progression and improve the quality of life in patients with multiple myeloma. Dr. Callander provides an overview of the history of maintenance therapy and discusses the new and exciting treatment options available. She also delves into potential future therapies that are currently under study.

Many bone marrow/stem cell transplant patients experience neuropathy (nerve pain) after transplant. This presentation describes the various types of neuropathy patients may experience and reviews popular treatment options.